U. S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 10-Q


              [x] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended June 30, 2001
                           Commission File No. 2-70197


                              OCEAN BIO-CHEM, INC.
--------------------------------------------------------------------------------

             (Exact name of registrant as specified in its charter)

 -------------------------------------------------------------------------------
          Florida                                  59-156432
  (State of other jurisdiction of               (I.R.S. Employer
   incorporation or organization)               Identification No.)


      Registrant's telephone number, including area code - (954) 587-6280

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

        Yes [ X ]                       No  [  ]

      Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.

           $.01 Par Value Common Stock, 10,000,000 shares authorized.
            4,199,899 shares issued and outstanding at June 30, 2001










<PAGE>


                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES

                                      INDEX



   Description                                                        Page

Part I:

  Item 1. - Financial Statements:

      Consolidated balance sheets as of June
          30, 2001 and December 31, 2000                               3

      Consolidated statements of operations for
          the three and six months ended June 30,
          2001 and 2000                                                4

       Consolidated statements of changes in
          shareholders' equity for the six  months
          ended June 30, 2001 and 2000                                 5

       Consolidated statements of cash flows
          for the six months ended June 30, 2001
          and 2000                                                     6

  Item 2. -     Management's Discussion and Analysis
                of Financial Condition and Results of Operations     7-8


Part II:

  Item 1. - Legal Proceedings                                          9
  Item 2. - Changes in Securities                                      9
  Item 3. - Defaults upon Senior Securities                            9
  Item 4. - Submission of Matters to Vote by Security Holders          9
  Item 5. - Other Matters                                             10
  Item 6. - Exhibits and Reports on Form 8-K                          10


Signatures                                                            11












                                        2
<PAGE>

                         PART I - Financial Information

 Item l.  Financial Statements

                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS

                                     ASSETS

<TABLE>
<CAPTION>

                                                         JUNE 30,      DECEMBER 31,
                                                           2001            2000
                                                       -----------    -------------
                                                       (Unaudited)

                                                    <c>             <c>
Current assets:
Cash                                                   $   164,728     $   123,515
Trade accounts receivable net of allowances for
  doubtful accounts of approximately $23,000
  at June 30, 2001 and December   31, 2000,
   respectively                                          3,096,578       3,417,827
Inventories                                              4,662,124       4,506,987
Due from officer                                                --         161,100
Prepaid expenses and other current assets                  378,284         289,441
                                                       -----------     -----------
    Total current assets                                 8,301,714       8,498,870
                                                       -----------     -----------

Property, plant and equipment, net                       6,070,659       5,643,550
                                                       -----------     -----------

Other assets:
Funds held in escrow for equipment                          27,380          41,506
Trademarks, trade names and patents, net                   341,935         353,431
Deposits and other assets                                  333,115         274,670
Due from affiliated companies, net                         398,934         598,237
                                                       -----------     -----------
    Total other assets                                   1,101,364       1,267,844
                                                       -----------     -----------

    Total assets                                       $15,473,737     $15,410,264
                                                       ===========     ===========

                      LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable - trade                               $ 1,999,480     $ 2,119,865
Note payable - bank                                      4,122,388       4,250,000
Current portion of long-term debt                          464,982         355,306
Accrued expenses payable                                   231,979         120,356
                                                       -----------     -----------
     Total current liabilities                           6,818,829       6,845,527
                                                       -----------     -----------

Long-term debt, less current portion                     3,946,708       3,892,445
                                                       -----------     -----------

Shareholders' equity:
Common stock - $.01 par value 10,000,000 shares
     authorized, 4,199,889 and 4,105,889 shares
     issued and outstanding at June 30, 2001 and
     December 31, 2000, respectively                        41,999          41,060
Additional paid-in capital                               3,744,819       3,720,377
Foreign currency translation adjustment                (   227,124)    (   209,398)
Retained earnings                                        1,156,701       1,128,448
                                                       -----------     -----------
                                                         4,716,395       4,680,487
Less cost of common stock in treasury,
    5,789 shares at June 30, 2001 and
    December 31, 2000, respectively                    (     8,195)    (     8,195)
                                                       -----------     -----------
                                                         4,708,200       4,672,292
                                                       -----------     -----------
Total liabilities and shareholders' equity             $15,473,737     $15,410,264
                                                       ===========     ===========

</TABLE>

                                        3

<PAGE>

                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)


<TABLE>
<CAPTION>

                                            FOR THE THREE MONTHS            FOR THE SIX MONTHS
                                            --------------------            ------------------
                                                ENDED JUNE 30,                ENDED JUNE 30,
                                            2001          2000            2001              2000
                                            ----          ----            ----              ----

                                     <c>            <c>             <c>              <c>
Gross sales                             $5,033,602     $4,118,783      $8,578,349       $7,823,945

Allowances                                 420,293        403,718         731,834          836,746
                                        ----------     ----------      ----------       ----------

Net sales                                4,613,309      3,715,065       7,846,515        6,987,199
Cost of goods sold                       3,298,286      2,530,688       5,847,920        4,792,886
                                        ----------     ----------      ----------       ----------

Gross profit                             1,315,023      1,184,377       1,998,595        2,194,313
                                        ----------     ----------      ----------       ----------

Costs and expenses:
Advertising and promotion                  152,990        163,336         292,812          346,488
Selling and administrative                 672,581        826,858       1,382,258        1,554,193
Interest expense                           140,010        132,294         285,010          254,200
                                        ----------     ----------      ----------       ----------
    Total cost and expenses                965,581      1,122,488       1,960,080        2,154,881
                                        ----------     ----------      ----------       ----------

Income from operations                     349,442         61,889          38,515           39,432
Interest income                                285          3,144           1,738            8,936
                                        ----------     ----------      ----------       ----------

Income before income taxes                 349,727         65,033          40,253           48,368
Provision for income taxes                  12,000         21,500          12,000           15,000
                                        ----------     ----------      ----------       ----------

Net income                                 337,727         43,533          28,253           33,368

Other comprehensive income,
   net of income taxes:
Foreign currency translation
  adjustment                                 6,030        (23,511)        (17,726)        (30,200)
                                        ----------     ----------      ----------       ----------
Comprehensive income                    $  343,757     $   20,022      $   10,527       $    3,168
                                        ==========     ==========      ==========       ==========

Earnings per
  common share                          $      .09     $      .01      $      .01       $      .01
                                        ==========     ==========      ===========      ==========



</TABLE>

Earnings  per share were  calculated  on the basis of  4,114,037  and  4,011,426
weighted average shares of common stock outstanding for the six months and three
months ended June 30, 2001 and 2000, respectively.

The Company has adopted  Statement of  Financial  Accounting  Standards  No. 130
which requires items of  comprehensive  income to be stated as part of the basic
financial  statements.  The only items of comprehensive income of the registrant
which  are  reflected  in the  accompanying  financial  statements  are  foreign
currency translation adjustments.

                                        4


<PAGE>
                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
                       CONSOLIDATED STATEMENTS OF CHANGES
                             IN SHAREHOLDERS' EQUITY
                            FOR THE SIX MONTHS ENDED
                             JUNE 30, 2001 AND 2000
                                   (UNAUDITED)
<TABLE>
<CAPTION>
                                                                          Foreign
                              Common stock             Additional        currency         Retained     Treasury
                          Shares         Amount      paid-in capital    adjustment        earnings        stock         Total
                          ------         ------      ---------------    ----------        --------     --------         -----

                      <c>            <c>            <c>              <c>              <c>           <c>             <c>
January 1,
   2000                  3,822,499      $38,225        $3,282,932       ($ 160,872)      $1,764,051    ($  6,875)      $4,917,461


Net income                                                                                   33,368                        33,368

Issuances of stock         283,390        2,835           437,446                        (  390,781)                       49,500

Foreign currency
  translation
  adjustment                                                            (    30,200)                                   (   30,200)

June 30,
  2000                   4,105,889      $41,060        $3,720,378       ($  191,072)     $1,406,638    ($  6,875)      $4,970,129
  ----                   ---------      -------        ----------       -----------      ----------    ---------       ----------



January 1,
   2001                  4,105,889      $41,060        $3,720,377       ($  209,398)     $1,128,448    ($  8,195)      $4,672,292
   ====                  =========      =======        ==========       ===========      ==========    =========       ==========


Net income                                                                                   28,253                        28,253


Issuances of stock          94,000           939            24,442                                                          25,381

Foreign currency
  translation
  adjustment                                                            (    17,726)                                   (   17,726)
                         ---------      -------        ----------       ------------     ---------     ---------       ----------
June 30,
  2001                   4,199,889      $41,999        $3,744,819       ($  227,124)     $1,156,701    ($  8,195)      $4,708.200
  ====                   =========      =======        ==========       ===========      ==========    =========       ==========



</TABLE>





                                        5



<PAGE>
                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                        FOR THE SIX MONTHS ENDED JUNE 30,
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                           2001                 2000


                                                                    <c>                  <c>
Cash flow provided by operating activities:
Net income                                                             $     28,253         $    33,368
                                                                       ------------         -----------

Adjustments to reconcile net income
   to net cash provided by operations:
Depreciation and amortization                                               215,145             168,997
Changes in assets and liabilities:
  Decrease in accounts receivable                                           321,249             652,051
   (Increase) in inventory                                             (    155,137)        (   616,213)
   (Increase) decrease in prepaid expenses
   and other current assets                                                  72,257         (   141,198)
  Increase (decrease) in accounts payable,
    accrued expenses and other                                         (     67,208)        (   166,689)
                                                                       -------------        ------------
      Net cash provided (used) by operating activities                      414,559         (    69,684)
                                                                       -------------        ------------
Cash flows from financing activities:
  Net increases (reductions) under line of credit                      (    127,611)            200,000
  Reduction in advances from affiliates                                     199,303             235,362
  Borrowings (payments) on debts, net                                       163,939         (   152,333)
  Common stock transactions                                                  25,381              49,500
                                                                       -------------        ------------
      Net cash provided by financing activities                             261,012             332,529
                                                                       -------------        ------------
Cash flows from investing activities:
   Purchases of property, plant, equipment, net
      of funds held in escrow                                          (    616,632)        (   504,658)
                                                                       -------------        ------------
     Net cash (used) by investing activities                           (    616,632)        (   504,658)
                                                                       -------------        ------------
  Increase (decrease) in cash prior to effect of
     foreign currency translation adjustment                                 58,939         (   241,813)
  Effect of foreign currency translation adjustment
    on cash                                                            (     17,726)        (    30,200)
                                                                       -------------        ------------
     Net increase (decrease) in cash                                         41,213         (   272,013)

 Cash at beginning of period                                                123,515             433,772
                                                                       -------------        ------------
 Cash at end of period                                                  $   164,728          $  161,759
                                                                       =============        ============
Supplemental information:
Cash used for payment of interest during period                         $   285,010           $ 254,200
                                                                       =============        ============
Cash used for payment of income taxes during
period                                                                  $     -0-             $ 257,800
                                                                       =============        ============

The company had no cash equivalents at June 30, 2001 and 2000.

</TABLE>

                                        6

<PAGE>
                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

     1. The information contained in this report is unaudited,  but reflects all
adjustments  which are, in the opinion of the  management,  necessary for a fair
statement of results of the interim periods, consisting only of normal recurring
accruals. The results for such interim periods are not necessarily indicative of
results to be expected for the full year.

Certain  financial  statement  items for the three and six months ended June 30,
2000 have been reclassified to conform with the 2001 presentation.

ITEM 2        MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
              AND RESULTS OF OPERATIONS

Liquidity and Capital Resources
-------------------------------

The primary sources of the Registrant's liquidity are its operations, short-term
borrowings  from a  commercial  bank  pursuant  to a  revolving  line of  credit
arrangement,  and  other  borrowings.  The total  borrowings  under the line are
secured by trade receivables, inventories, and other assets, and can aggregate a
maximum amount of $5,000,000.  Borrowings  under the line are due on demand from
the bank.  Under the terms of the line,  the  Registrant is required to maintain
minimum working  capital of $1,500,000,  a maximum debt to tangible net worth of
ratio of 2.5 to 1 and a minimum debt service  coverage  factor of 1.15 times. As
of  June  30,  2001,  the  amount  outstanding  pursuant  to this  facility  was
$4,122,388  and,  as of such  date the  Registrant  was not in  compliance  with
certain of the applicable  loan  covenants.  The lender has agreed to waive such
violations through September 30, 2001.

On March 25, 1999,  The  Registrant  borrowed  $400,000  from an entity owned by
certain  officers of the Company.  The obligation  requires  monthly payments of
principal and interest at prevailing rates through maturity during April,  2004,
when a final balloon payment is due.

The  Registrant  is  involved  in  making  sales  in the  Canadian  market  and,
accordingly, is subject to fluctuations of the Canadian currency. The Registrant
does not engage in currency hedging and deals with such risk as a pricing issue.


Results of Operations For The Three Month Period April 1- June 30:
-----------------------------------------------------------------
Gross sales  increased  approximately  22.2 % or $914,800 for the quarter  ended
June  30,  2001  when  compared  to the  same  quarter  of the  preceding  year.
Management attributes this primarily to increased sales of new automotive fluids
products and a sales price  increase  implemented  late in the first  quarter of
2001.








                                        7


<PAGE>

Cost of goods sold  increased as a percentage  of net sales when  comparing  the
quarter ended June 30, 2001 with the comparable quarter in 2000. The percentages
were 71.5% and 68.1% for the quarters  ended 2001 and 2000,  respectively.  This
change  was  primarily  due to higher raw  chemical  costs, anticipated  lower
margins on the  automotive  fluids as compared to the marine product line and
higher manufacturing overhead at the Company's Alabama plant.

Selling and administrative expenses decreased approximately $154,300 or 18.7%
comparing the quarters ended June 30, 2001 and June 30, 2000. Such decrease was
primarily due to decreased professional fees offset by increased personnel costs
associated with the new automotive line of products.

Advertising and promotion decreased approximately $10,300 or 6.3% comparing the
three months ended June 30, 2001 and 2000.  This was  primarily due to timing of
advertising in 2001. The overall program for 2001 is lower than 2000.

Interest  expense  increased  approximately  $7,700 during the current quarter.
This change was primarily due to costs associated with increased  borrowings
which were mitigated by the impact of decreasing interest rates.


Results of Operations For the Six Month Period January 1 - June 30:
------------------------------------------------------------------
Gross Sales  increased  9.6% or  approximately  $754,400 when  comparing the six
month  periods  of 2001  and  2000.  Management  attributes  this  primarily  to
increased  sales of new  automotive  fluids  products and a sales price increase
implemented late in the first quarter of 2001.

Cost of goods sold increased as a percentage of net sales when comparing the six
months ended June 30, 2001 with the comparable  period in 2000. The  percentages
were  74.5%  and  68.6%  for  the  six  month   periods  ended  2001  and  2000,
respectively.  This  change  was  primarily  due to higher raw  chemical  costs,
anticipated  lower  margins on the  automotive  fluids as compared to the marine
product line and higher manufacturing overhead at the Company's Alabama plant.

Advertising and promotion expenses decreased approximately 15.5% or $53,700 when
comparing  the six months  ended June 30, 2001 to the six months  ended June 30,
2000. This was primarily due to a planned increase in the advertising budget.

Selling and administrative  expenses decreased for the six months ended June 30,
2001 by  approximately  $171,900 or 11.1% when  compared to the six months ended
June 30, 2000.  Such decrease was primarily due to decreased  professional  fees
offset by increased  personnel costs  associated with the new automotive line of
products.

Interest expense  increased during the six month period in 2001 by approximately
$30,800 when compared to the six month period of 2000. This change was primarily
due to costs  associated with increased  borrowings  which were mitigated by the
impact of decreasing interest rates.






                                        8

<PAGE>
Forward-looking Statements:

Certain statements contained herein,  including without limitation  expectations
as to future sales and operating results,  constitute forward-looking statements
pursuant to the safe harbor  provisions  of the  Private  Securities  Litigation
Reform Act of 1995. For this purpose,  any  statements  contained in this report
that  are not  statements  of  historical  fact  may be  deemed  forward-looking
statements.  Without  limiting the  generality of the  foregoing,  words such as
"may", "will", "expect",  "anticipate",  "intend", "could" or the negative other
variations   thereof  or  comparable   terminology   are  intended  to  identify
forward-looking  statements.  These statements  involve known and unknown risks,
uncertainties  and other factors which may cause actual results,  performance or
achievements of the Company to be materially  different from any future results,
performance  or  achievements  expressed  or  implied  by  such  forward-looking
statements.  Factors which may affect the Company's results include, but are not
limited to, the highly competitive nature of the Company's industry; reliance on
certain  key  customers;  consumer  demand for marine  recreational  vehicle and
automotive products; advertising and promotional efforts, and other factors. The
Company will not undertake and specifically declines any obligation to update or
correct any forward-looking  statements to reflect events or circumstances after
the date of such  statements  or to reflect the  occurrence  of  anticipated  or
unanticipated events.

PART II:  OTHER INFORMATION

Item l - Legal Proceedings: See the Registrant's Form 10-Q for the quarter ended
     March 31, 2001 for disclosure of matters associated with North American Oil
     Company,  Inc. v. Star Brite  Distributing,  Inc.  with  respect to a court
     ruling dated March 30, 2001.  Subsequent thereto,  the court ruled to defer
     ruling on further  issues related to the case,  specifically  including the
     subject of awarding legal fees to the plaintiff, until the Company's appeal
     is resolved.

Item 2 -   Changes in Securities:  Not applicable

Item 3 -   Defaults Upon Senior Securities:  Not applicable

Item 4 - Submission of Matters to Vote of Security Holders: On June 15, 2001, at
     the  Registrant's  annual meeting of  shareholders,  six  directors;  Peter
     Dornau,  Jeffrey Tieger,  Edward Anchel,  Laz Schneider,  James Kolisch and
     John B. Turner were elected.  Shareholders also approved Berkovits,  Lago &
     Co., LLP,  Certified Public  Accountants,  as independent  auditors for the
     year ending  December 31, 2001.  The tabulation of voting for the foregoing
     was as follows:

                                        For              Against         Abstain
           Peter Dornau              3,852,651            4,748           12,198
           Edward Anchel             3,852,651            4,748           12,198
           Jeffrey Tieger            3,852,651            4,748           12,198
           Laz Schneider             3,852,441            4,958           12,198
           James Kolisch             3,852,441            4,958           12,198
           John B. Turner            3,852,441            4,958           12,198

           Berkovits, Lago
               & Co.,LLP, CPA's     3,865,477            3,879              242


                                        9

<PAGE>

Item 5 -    Other Matters:  Not applicable

Item 6 -    Exhibits:  Not applicable

        (A)      Exhibits - Not applicable

        (B)      Reports on Form 8-K - Not applicable













































                                       10


<PAGE>
                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                                    OCEAN BIO-CHEM, INC.

Date: August 13, 2001                                /s/ Peter Dornau
                                                    Peter G. Dornau
                                                    Chairman of the Board and
                                                    Chief Executive Officer


                                                     /s/ Edward Anchel
                                                    Edward Anchel
                                                    Chief Financial Officer